Worms found in Nutramigen and Enfamil baby formulas

Similac is the #1 brand fed in hospitals. Abbott Laboratories owns Similac. Revenue – US$41.9 million in 2024.

Mead Johnson owns the Enfamil brand. Mead Johnson is a subsidiary of Reckitt, an international consumer health and hygiene company. Revenue $US18.3 million in 2024

Article- September 11, 2024

Baby Formula Lawsuits -Similac and Enfamil

The Similac and Enfamil baby formula lawsuits center on allegations that Abbott Laboratories and Mead Johnson & Company failed to warn parents and healthcare providers about the increased risk of necrotizing enterocolitis (NEC) in premature infants linked to their cow's milk-based formula and fortifier products.

What is NEC?

Necrotizing enterocolitis (NEC) is a severe and often fatal gastrointestinal condition that primarily affects premature infants. NEC causes inflammation and bacterial invasion of the intestines, which can lead to the following:

Tissue death
Bowel perforation
Severe infections

According to the Merck Manual, an authoritative medical resource, NEC is the most prevalent gastrointestinal emergency among newborn infants. Over 90% of NEC cases occur in premature infants, affecting up to 8% of infants admitted to the NICU. The Mayo Clinic states that premature newborns exclusively fed breast milk have a significantly lower risk of developing NEC.

Due to their weaker immune and digestive systems, premature infants struggle to combat infections. They also have reduced blood flow, and the resulting lack of oxygen reaching the intestinal tissue can create conditions for bacteria to enter the abdomen or bloodstream.

Link: https://www.integrityforjustice.com/practice-areas/baby-formula-similac-and-enfamil/